Selected research
Market Outlook & Growth Opportunities
Global Fetal Monitoring Software Market Outlook and Growth Opportunities 2026
Market perspective
The global Fetal Monitoring Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Fetal Monitoring Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Fetal Monitoring Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Fetal Monitoring Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Fetal Monitoring Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Fetal Monitoring Software market include Janitri, Astraia, OBIX, GE Healthcare, PeriGen, Toitu Co., Ltd., Huntleigh, Medline and FHMCAT, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Fetal Monitoring Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Fetal Monitoring Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Fetal Monitoring Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Fetal Monitoring Software market.
Fetal Monitoring Software Segment by Company
Janitri
Astraia
OBIX
GE Healthcare
PeriGen
Toitu Co., Ltd.
Huntleigh
Medline
FHMCAT
Fetal Monitoring Software Segment by Type
Cloud Based
Local Based
Fetal Monitoring Software Segment by Application
Household
Medical
Other
Fetal Monitoring Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Fetal Monitoring Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Fetal Monitoring Software key companies, revenue, market share, and recent developments.
3. To split the Fetal Monitoring Software breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Fetal Monitoring Software market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Fetal Monitoring Software significant trends, drivers, influence factors in global and regions.
6. To analyze Fetal Monitoring Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fetal Monitoring Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fetal Monitoring Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fetal Monitoring Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Fetal Monitoring Software industry.
Chapter 3: Detailed analysis of Fetal Monitoring Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Fetal Monitoring Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Fetal Monitoring Software in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud Based
- Local Based
Applications
- Household
- Medical
- Other
Companies covered
- Janitri
- Astraia
- OBIX
- GE Healthcare
- PeriGen
- Toitu Co., Ltd.
- Huntleigh
- Medline
- FHMCAT
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Fetal Monitoring Software Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Fetal Monitoring Software Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Fetal Monitoring Software Market Dynamics
- 2.1 Fetal Monitoring Software Industry Trends
- 2.2 Fetal Monitoring Software Industry Drivers
- 2.3 Fetal Monitoring Software Industry Opportunities and Challenges
- 2.4 Fetal Monitoring Software Industry Restraints
3 Fetal Monitoring Software Market by Company
- 3.1 Global Fetal Monitoring Software Company Revenue Ranking in 2025
- 3.2 Global Fetal Monitoring Software Revenue by Company (2021-2026)
- 3.3 Global Fetal Monitoring Software Company Ranking (2024-2026)
- 3.4 Global Fetal Monitoring Software Company Manufacturing Base and Headquarters
- 3.5 Global Fetal Monitoring Software Company Product Type and Application
- 3.6 Global Fetal Monitoring Software Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Fetal Monitoring Software Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Fetal Monitoring Software Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Fetal Monitoring Software Market by Type
- 4.1 Fetal Monitoring Software Type Introduction
- 4.1.1 Cloud Based
- 4.1.2 Local Based
- 4.2 Global Fetal Monitoring Software Sales Value by Type
- 4.2.1 Global Fetal Monitoring Software Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Fetal Monitoring Software Sales Value by Type (2021-2032)
- 4.2.3 Global Fetal Monitoring Software Sales Value Share by Type (2021-2032)
5 Fetal Monitoring Software Market by Application
- 5.1 Fetal Monitoring Software Application Introduction
- 5.1.1 Household
- 5.1.2 Medical
- 5.1.3 Other
- 5.2 Global Fetal Monitoring Software Sales Value by Application
- 5.2.1 Global Fetal Monitoring Software Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Fetal Monitoring Software Sales Value by Application (2021-2032)
- 5.2.3 Global Fetal Monitoring Software Sales Value Share by Application (2021-2032)
6 Fetal Monitoring Software Regional Value Analysis
- 6.1 Global Fetal Monitoring Software Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Fetal Monitoring Software Sales Value by Region (2021-2032)
- 6.2.1 Global Fetal Monitoring Software Sales Value by Region: 2021-2026
- 6.2.2 Global Fetal Monitoring Software Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Fetal Monitoring Software Sales Value (2021-2032)
- 6.3.2 North America Fetal Monitoring Software Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Fetal Monitoring Software Sales Value (2021-2032)
- 6.4.2 Europe Fetal Monitoring Software Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Fetal Monitoring Software Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Fetal Monitoring Software Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Fetal Monitoring Software Sales Value (2021-2032)
- 6.6.2 South America Fetal Monitoring Software Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Fetal Monitoring Software Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Fetal Monitoring Software Sales Value Share by Country, 2025 VS 2032
7 Fetal Monitoring Software Country-level Value Analysis
- 7.1 Global Fetal Monitoring Software Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Fetal Monitoring Software Sales Value by Country (2021-2032)
- 7.2.1 Global Fetal Monitoring Software Sales Value by Country (2021-2026)
- 7.2.2 Global Fetal Monitoring Software Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.7.2 France Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.14.2 China Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.17.2 India Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Fetal Monitoring Software Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Fetal Monitoring Software Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Fetal Monitoring Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Janitri
- 8.1.1 Janitri Company Information
- 8.1.2 Janitri Business Overview
- 8.1.3 Janitri Fetal Monitoring Software Revenue and Gross Margin (2021-2026)
- 8.1.4 Janitri Fetal Monitoring Software Product Portfolio
- 8.1.5 Janitri Recent Developments
- 8.2 Astraia
- 8.2.1 Astraia Company Information
- 8.2.2 Astraia Business Overview
- 8.2.3 Astraia Fetal Monitoring Software Revenue and Gross Margin (2021-2026)
- 8.2.4 Astraia Fetal Monitoring Software Product Portfolio
- 8.2.5 Astraia Recent Developments
- 8.3 OBIX
- 8.3.1 OBIX Company Information
- 8.3.2 OBIX Business Overview
- 8.3.3 OBIX Fetal Monitoring Software Revenue and Gross Margin (2021-2026)
- 8.3.4 OBIX Fetal Monitoring Software Product Portfolio
- 8.3.5 OBIX Recent Developments
- 8.4 GE Healthcare
- 8.4.1 GE Healthcare Company Information
- 8.4.2 GE Healthcare Business Overview
- 8.4.3 GE Healthcare Fetal Monitoring Software Revenue and Gross Margin (2021-2026)
- 8.4.4 GE Healthcare Fetal Monitoring Software Product Portfolio
- 8.4.5 GE Healthcare Recent Developments
- 8.5 PeriGen
- 8.5.1 PeriGen Company Information
- 8.5.2 PeriGen Business Overview
- 8.5.3 PeriGen Fetal Monitoring Software Revenue and Gross Margin (2021-2026)
- 8.5.4 PeriGen Fetal Monitoring Software Product Portfolio
- 8.5.5 PeriGen Recent Developments
- 8.6 Toitu Co., Ltd.
- 8.6.1 Toitu Co., Ltd. Company Information
- 8.6.2 Toitu Co., Ltd. Business Overview
- 8.6.3 Toitu Co., Ltd. Fetal Monitoring Software Revenue and Gross Margin (2021-2026)
- 8.6.4 Toitu Co., Ltd. Fetal Monitoring Software Product Portfolio
- 8.6.5 Toitu Co., Ltd. Recent Developments
- 8.7 Huntleigh
- 8.7.1 Huntleigh Company Information
- 8.7.2 Huntleigh Business Overview
- 8.7.3 Huntleigh Fetal Monitoring Software Revenue and Gross Margin (2021-2026)
- 8.7.4 Huntleigh Fetal Monitoring Software Product Portfolio
- 8.7.5 Huntleigh Recent Developments
- 8.8 Medline
- 8.8.1 Medline Company Information
- 8.8.2 Medline Business Overview
- 8.8.3 Medline Fetal Monitoring Software Revenue and Gross Margin (2021-2026)
- 8.8.4 Medline Fetal Monitoring Software Product Portfolio
- 8.8.5 Medline Recent Developments
- 8.9 FHMCAT
- 8.9.1 FHMCAT Company Information
- 8.9.2 FHMCAT Business Overview
- 8.9.3 FHMCAT Fetal Monitoring Software Revenue and Gross Margin (2021-2026)
- 8.9.4 FHMCAT Fetal Monitoring Software Product Portfolio
- 8.9.5 FHMCAT Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst